trending Market Intelligence /marketintelligence/en/news-insights/trending/PIenTCAhsOACm710u07j8Q2 content esgSubNav
In This List

Mediclinic International names CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mediclinic International names CEO

Mediclinic International plc named Carel Aron van der Merwe to be CEO.

The effective date of the appointment will be mutually agreed upon but cannot be later than Aug. 1, 2018.

Van der Merwe is currently the company's chief clinical officer. He will replace Danie Meintjes, who will retire from his CEO and director roles no later than July 31, 2018.